U thËn lµnh tÝnh
U thËn lµnh tÝnh
!"#
!"#
!$%&'(!
!$%&'(!
!()*"
!()*"
+
+
,-
,-
.
.
-"(/
-"(/
0
0
121
121
3
3
2
2
4
4
"/5%6%&
"/5%6%&
'(78,)%'9
'(78,)%'9
$5:%(9
$5:%(9
$;%
$;%
"#
"#
2.
2.
,-
,-
$6"%#:%(<6
$6"%#:%(<6
=>/'()?.
=>/'()?.
@8AB<%)(<C7DC'%
@8AB<%)(<C7DC'%
$5:%(9
$5:%(9
,-$5:%(9
,-$5:%(9
3.
3.
-"(/
-"(/
-"(,-E6>F
-"(,-E6>F
=>/'()G.
=>/'()G.
=6%C5/%:5>H$
=6%C5/%:5>H$
I(JKAC'6%C
I(JKAC'6%C
-"(/
-"(/
-"(/
-"(/
-"(/
-"(/
4.
4.
1211
1211
Angiomyolipome
Angiomyolipome
(AML)
(AML)
LM21A19
LM21A19
=6%K55N5$A%/%AO
=6%K55N5$A%/%AO
=>/'()+1P
=>/'()+1P
=6%DCQ4PRS78ABC,L%'%
=6%DCQ4PRS78ABC,L%'%
$),9(<9T $UV'9
$),9(<9T $UV'9
121
121
5.
5.
2
2
LM2
LM2
=6%$5WA,L%K55N(<
=6%$5WA,L%K55N(<
J(
J(
=>/'()1P
=>/'()1P
=6%DC85':$"$)
=6%DC85':$"$)
XC"%V5/%121"Y;T@
XC"%V5/%121"Y;T@
>H<TKZ5>H%(L%
>H<TKZ5>H%(L%
2
2
2
2
2
2